SAGE stock forecast for 2023 – 2027

Are you interested in Sage Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the SAGE stock price in 2022-2027. Is SAGE a good long term stock? When should I take profit in Sage Therapeutics stock? Buy or sell stock? Will SAGE stock price go up? What are analysts’ forecasts for SAGE stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. SAGE stock returns are also predicted based on historical data.

According to our research, SAGE stock is a bad long-term investment. SAGE share price has been in a bear cycle for the past year. Sage Therapeutics, Inc. stock trend is negative.

Sage Therapeutics company info

Industry Biotechnology
Address 215 First Street, Cambridge, MA, 02142, United States
Website https://www.sagerx.com

Forecasting

52 Week High: 39.4708 USD
52 Week Low: 1.37764 USD
1 Year Forecast: 2.828 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 2.4B
52 Week Change: -38.651%
52 Week High: 88.51 USD
52 Week Low: 36.02 USD
Beta: 1.44242
50 Day Moving Average: 41.01
90 Day Moving Average: 40.828
200 Day Moving Average: 42.72
Resistance Level: 43.9079
Pivot Point: 40.263
Support Level: 37.1587
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0

Sage Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Sage Therapeutics Stock Forecast for 2023

January 2023 4.08 3 -26.47%
February 2023 2.02 1 -50.5%
March 2023 0.99 0 -100%
April 2023 0 0 -100%
May 2023 0 0 -100%
June 2023 0 0 -100%
July 2023 0 0 -100%
August 2023 0 0 -100%
September 2023 0 0 -100%
October 2023 0 0 -100%
November 2023 0 0 -100%
December 2023 0 0 -100%

Sage Therapeutics Stock Forecast for 2024

January 2024 0 0 -100%
February 2024 0 0 -100%
March 2024 0 0 -100%
April 2024 0 0 -100%
May 2024 0 0 -100%
June 2024 0 0 -100%

Other companies stock forecasts